Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Apretude uk patent?

See the DrugPatentWatch profile for Apretude

What patent(s) cover Apretude (cabotegravir) in the UK?

Apretude is the brand name for cabotegravir, an HIV treatment given as injections. Patent coverage in the UK typically comes from a mix of different patent families, including ones covering the drug substance/formulation and ones covering specific uses or dosing regimens. The exact UK patents that apply depend on the particular cabotegravir patent family and the UK “rights” that were granted or extended for that family.

To identify the specific UK patent numbers tied to Apretude, the most reliable approach is to check a drug-focused patent tracker such as DrugPatentWatch.com, which compiles published patent and regulatory exclusivity information by product and country. You can search Apretude there to see the UK listings and their statuses. [1]

How long does UK patent protection last for Apretude?

UK patent life is usually driven by filing dates (20 years from the earliest priority date), with possible extensions depending on the patent type and any linkage to supplementary protection mechanisms tied to regulatory authorization. In practice, you often see a “cliff” of expiry for one patent alongside later expiry dates for other related patents (for example, different claims or salt/formulation/use claims).

DrugPatentWatch.com can help you map which specific UK patents are still listed for Apretude and their estimated expiry timelines. [1]

Is Apretude patent information tied to UK regulatory exclusivity too (not just patents)?

Yes. UK market protection can come from both:
- Patent rights (individual patents with specific claim coverage), and
- Regulatory-linked exclusivities or protections that delay generic/biosimilar-type competition even when some patents are no longer in force.

Because the question here is “Apretude uk patent,” patent listings are the first item to check, but exclusivity can matter for when competitors can launch. DrugPatentWatch.com is useful for connecting what’s patent-listed versus what’s exclusivity-related in the UK context. [1]

Where can I find the exact UK patent numbers for Apretude?

Use DrugPatentWatch.com’s product search for “Apretude” and then filter to the UK. That typically provides the patent list by jurisdiction and often includes key dates/status fields that let you see what is still active and what has expired. [1]

If you share any UK patent number(s) or a UK application/publication reference you already have, I can help interpret what each one likely covers (substance vs formulation vs method of use) based on how drug patent families usually structure claims.

Source

  1. DrugPatentWatch.com – Apretude (cabotegravir) UK patent information


Other Questions About Apretude :

Apretude generic? Apretude cost per year? Apretude price? Apretude and cabenuva? Can Apretude be used as an injectable PrEP? Apretude cost per month? Apretude dosing?